Is GENB or GHRS more undervalued in 2026?

CirclFi compares Generate Biomedicines, Inc. (GENB) and GH Research PLC (GHRS) using 13 institutional-grade valuation models. GENB has a Quality of Company score of 1.8/10 while GHRS scores 4.4/10.

Which is a better buy — GENB or GHRS?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do GENB and GHRS valuations compare?

GENB at $13.09 and GHRS at $22.38 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

GENB vs GHRS Valuation Comparison 2026 — Intrinsic Value Analysis

GENB

Biotechnology

Generate Biomedicines, Inc.

Quality

1.8

out of 10

Value Trap

—

Price

$13.09

Last close

Models

8/13

Active

GHRS

Biotechnology

GH Research PLC

Quality

4.4

out of 10

Value Trap

SAFE

Price

$22.38

Last close

Models

7/13

Active

Model-by-Model Comparison

Model	Type	GENB Fair Value	GENB Upside	GHRS Fair Value	GHRS Upside
Bayesian DCF	Intrinsic	$3.47	-73.5%	$3.69	-83.5%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$5.70	-56.4%	$2.62	-88.3%
PWERM	Option-Based	$8.93	-31.7%	$20.86	-6.8%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for GENB vs GHRS — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

GENB vs GHRS — Which Stock Is More Undervalued?

GHRS scores higher with a 4.4/10 quality rating vs GENB's 1.8/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Generate Biomedicines, Inc. (GENB) and GH Research PLC (GHRS) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

GENB currently trades at $13.09 with a QOC of 1.8/10, while GHRS trades at $22.38 with a QOC of 4.4/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).